<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01548820</url>
  </required_header>
  <id_info>
    <org_study_id>HBV resistance</org_study_id>
    <nct_id>NCT01548820</nct_id>
  </id_info>
  <brief_title>Resistance to Lamivudine in HBV Egyptian Patients</brief_title>
  <official_title>Pretreatment and On-treatment Indicators of Virologic Breakthrough in Chronic HBV Egyptian Patients Receiving Lamivudine Therapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ain Shams University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ain Shams University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      On treatment parameters for Lamivudine resistance in HBV treated Egyptian patients
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Primarily: To study the correlations between the following parameters in adult Egyptian
      patients with chronic viral hepatitis B before treatment:

        -  ALT.

        -  HBeAg.

        -  HBV-DNA by quantitative PCR.

        -  Biopsy (if possible). Secondarily: After receiving lamivudine therapy we will identify
           the impact of these parameters on viral breakthrough at 1 year of therapy.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2010</start_date>
  <completion_date type="Actual">January 2013</completion_date>
  <primary_completion_date type="Actual">November 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Resistance to Lamivudine Therapy</measure>
    <time_frame>1 year</time_frame>
    <description>Prevelance of Lamivudine resistance among HBV Egyptian cases pretreatment and on treatment parameters for Lamivudine therapy resistance</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">230</enrollment>
  <condition>Chronic Hepatitis B Virus Treatment</condition>
  <arm_group>
    <arm_group_label>Chronic HBV Egyptian patients</arm_group_label>
    <description>chronic HBV patients receiving Lamivudine therapy in hepatology clinic in the National Hepatology &amp; Tropical Medicine Research Institute in Egypt.</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      blood samples +/- tissue biopsy
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        chronic HBV patients receiving Lamivudine therapy in hepatology clinic in the National
        Hepatology &amp; Tropical Medicine Research Institute in Egypt in the period from 2007- 2011.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult patients &gt;18 years old

          -  Egyptian nationality

          -  Positive serology for HBsAg for more than 6 months

          -  Positive HBV viremia (above 2000IU/ml).

          -  Lamivudine monotherapy

        Exclusion Criteria:

          -  Anti-HBcIgM seropositivity

          -  Positive serology for HCV

          -  Positive serology for HDV

          -  Patients complicated with HCC
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Tropical medicine department</name>
      <address>
        <city>Cairo</city>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>September 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 6, 2012</study_first_submitted>
  <study_first_submitted_qc>March 6, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 8, 2012</study_first_posted>
  <last_update_submitted>September 8, 2013</last_update_submitted>
  <last_update_submitted_qc>September 8, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 10, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ain Shams University</investigator_affiliation>
    <investigator_full_name>Iman Fawzy Montasser</investigator_full_name>
    <investigator_title>Lecturer of tropical medicine , Ain Shams university</investigator_title>
  </responsible_party>
  <keyword>Hepatitis B virus</keyword>
  <keyword>Lamivudine</keyword>
  <keyword>Resistance to treatment</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hepatitis</mesh_term>
    <mesh_term>Hepatitis, Chronic</mesh_term>
    <mesh_term>Hepatitis B</mesh_term>
    <mesh_term>Hepatitis B, Chronic</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lamivudine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

